Celostatin Lar 30mg Injection
Marketer
Celon Laboratories Ltd
Salt Composition
Octreotide acetate (30mg)
Overview Celostatin Lar 30mg Injection
Octreotide long-acting 30mg injection treats acromegaly, carcinoid tumors, and bleeding esophageal varices, also preventing post-pancreatic surgery complications. Administration is strictly by a healthcare provider; self-injection is unsafe. Dosage and frequency are determined solely by your physician. Consistent use maximizes therapeutic effect; discontinue only under medical supervision. Common side effects include diarrhea, abdominal pain, nausea, constipation, gas, and headache. Report persistent or worsening side effects. Prior to treatment, disclose any liver conditions and all other medications you are currently using.
Primary Ingredients of Celostatin Lar 30mg Injection
There is no text provided to rephrase.
Uses of Celostatin Lar 30mg Injection
Overgrowth of the extremities | Neuroendocrine tumors | Esophageal variceal hemorrhage
Major Benefits of Celostatin Lar 30mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Celostatin Lar 30mg Injection:
- Diarrhea
- Abdominal pain
- Nausea
- Constipation
- Flatulence
- Headache
- Increased glucose level in blood
- Injection site reaction
How to use Celostatin Lar 30mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Celostatin Lar 30mg Injection works:
Celostatin Lar 30mg Injection mimics the action of somatostatin, a naturally occurring human hormone regulator. By suppressing the activity of various hormones, including growth hormone, it reduces gastrointestinal bleeding through vasoconstriction in the esophagus.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Celostatin Lar 30mg Injection may pose unknown risks. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
The injectable medication Celostatin Lar 30mg is typically deemed safe for use in pregnancy. Preclinical trials in animals have revealed minimal or no negative consequences for fetal development; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers may likely use Celostatin Lar 30mg Injection without significant risk to their infants. Available human data indicates minimal danger to the baby.
DrivingSAFE
Driving ability is typically unaffected by Celostatin Lar 30mg Injection.
KidneySAFE IF PRESCRIBED
Celostatin Lar 30mg Injection poses no safety concerns for individuals with renal impairment. Dosage modification for Celostatin Lar 30mg Injection is unnecessary in such patients.
LiverCAUTION
Patients with liver impairment should use Celostatin Lar 30mg Injection cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Celostatin Lar 30mg Injection :
Should you forget a Celostatin Lar 30mg Injection, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Celostatin Lar 30mg Injection
| Label | Value |
|---|---|
| Chemical Category | Somatostatin analogs |
| Developing Habits | No. |
| Treatment Category | Endocrine Signals |
| Active Class | Somatostatin analogs |
3,018 People bought this recently